Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.

Teunissen CE, Tumani H, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Federiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Jimenez CR, Johnson MH, Killestein J, Krasulova E, Kuhle J, Magnone MC, Petzold A, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Deisenhammer F, Giovannoni G, Hemmer B.

Mult Scler Int. 2011;2011:246412. doi: 10.1155/2011/246412. Epub 2011 Jul 18.

PMID:
22096631
[PubMed]
Free PMC Article
2.

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Rajda C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F.

Neurology. 2009 Dec 1;73(22):1914-22. doi: 10.1212/WNL.0b013e3181c47cc2.

PMID:
19949037
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Biobanking of CSF: international standardization to optimize biomarker development.

Teunissen CE, Tumani H, Engelborghs S, Mollenhauer B.

Clin Biochem. 2014 Mar;47(4-5):288-92. doi: 10.1016/j.clinbiochem.2013.12.024. Epub 2014 Jan 2.

PMID:
24389077
[PubMed - in process]
4.

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2011 Jul 15;306(1-2):82-90. doi: 10.1016/j.jns.2011.03.038. Epub 2011 May 6.

PMID:
21550068
[PubMed - indexed for MEDLINE]
5.

Direct Analytical Sample Quality Assessment (DASQ) for Biomarker Investigation: qualifying CSF samples.

Greco V, Pieragostino D, Piras C, Aebersold R, Wiltfang J, Caltagirone C, Bernardini S, Urbani A.

Proteomics. 2014 Jul 15. doi: 10.1002/pmic.201300565. [Epub ahead of print]

PMID:
25044759
[PubMed - as supplied by publisher]
6.

An empirical survey on biobanking of human genetic material and data in six EU countries.

Hirtzlin I, Dubreuil C, Préaubert N, Duchier J, Jansen B, Simon J, Lobato De Faria P, Perez-Lezaun A, Visser B, Williams GD, Cambon-Thomsen A; EUROGENBANK Consortium.

Eur J Hum Genet. 2003 Jun;11(6):475-88.

PMID:
12774042
[PubMed - indexed for MEDLINE]
Free Article
7.

Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations.

D'Aguanno S, Del Boccio P, Bernardini S, Ballone E, Di Ilio C, Federici G, Urbani A.

Clin Chem Lab Med. 2007;45(4):437-49. Review.

PMID:
17439319
[PubMed - indexed for MEDLINE]
8.

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.

Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y.

Neurology. 2010 Jul 20;75(3):208-16. doi: 10.1212/WNL.0b013e3181e2414b.

PMID:
20644148
[PubMed - indexed for MEDLINE]
9.

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.

Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y.

J Neurol Neurosurg Psychiatry. 2009 May;80(5):575-7. doi: 10.1136/jnnp.2008.150698.

PMID:
19372295
[PubMed - indexed for MEDLINE]
10.

A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica.

Takano R, Misu T, Takahashi T, Izumiyama M, Fujihara K, Itoyama Y.

Tohoku J Exp Med. 2008 May;215(1):55-9.

PMID:
18509235
[PubMed - indexed for MEDLINE]
Free Article
11.

Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.

Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G.

Int J Neurosci. 2010 Jan;120(1):71-5. doi: 10.3109/00207450903428970.

PMID:
20128675
[PubMed - indexed for MEDLINE]
12.

Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.

Vaknin-Dembinsky A, Brill L, Orpaz N, Abramsky O, Karussis D.

Mult Scler. 2010 Dec;16(12):1453-7. doi: 10.1177/1352458510380416. Epub 2010 Oct 8.

PMID:
20935029
[PubMed - indexed for MEDLINE]
13.

Biobanking for better healthcare.

Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P; Marble Arch International Working Group on Biobanking for Biomedical Research.

Mol Oncol. 2008 Oct;2(3):213-22. doi: 10.1016/j.molonc.2008.07.004. Epub 2008 Jul 30. Review.

PMID:
19383342
[PubMed - indexed for MEDLINE]
Free Article
14.

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases.

Spitzer P, Klafki HW, Blennow K, Buée L, Esselmann H, Herruka SK, Jimenez C, Klivenyi P, Lewczuk P, Maler JM, Markus K, Meyer HE, Morris C, Müller T, Otto M, Parnetti L, Soininen H, Schraen S, Teunissen C, Vecsei L, Zetterberg H, Wiltfang J.

Int J Alzheimers Dis. 2010 Sep 19;2010. pii: 548145. doi: 10.4061/2010/548145.

PMID:
20886057
[PubMed]
Free PMC Article
15.

Cerebrospinal fluid B-cell expansion in longitudinally extensive transverse myelitis associated with neuromyelitis optica immunoglobulin G.

Dale RC, Tantsis E, Merheb V, Brilot F.

Dev Med Child Neurol. 2011 Sep;53(9):856-60. doi: 10.1111/j.1469-8749.2011.03975.x. Epub 2011 Jun 17.

PMID:
21679355
[PubMed - indexed for MEDLINE]
16.

Banking of biological fluids for studies of disease-associated protein biomarkers.

Schrohl AS, Würtz S, Kohn E, Banks RE, Nielsen HJ, Sweep FC, Brünner N.

Mol Cell Proteomics. 2008 Oct;7(10):2061-6. doi: 10.1074/mcp.R800010-MCP200. Epub 2008 Aug 1. Review.

PMID:
18676364
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.

Dujmovic I, Mader S, Schanda K, Deisenhammer F, Stojsavljevic N, Kostic J, Berger T, Drulovic J, Reindl M.

J Neuroimmunol. 2011 May;234(1-2):124-30. doi: 10.1016/j.jneuroim.2011.01.007. Epub 2011 Feb 11.

PMID:
21316112
[PubMed - indexed for MEDLINE]
18.

Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.

Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS.

J Proteomics. 2011 Apr 1;74(4):371-88. doi: 10.1016/j.jprot.2010.11.010. Epub 2010 Nov 25. Review.

PMID:
21111852
[PubMed - indexed for MEDLINE]
19.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
[PubMed - indexed for MEDLINE]
20.

Use of anti-coronavirus antibody testing of cerebrospinal fluid for diagnosis of feline infectious peritonitis involving the central nervous system in cats.

Boettcher IC, Steinberg T, Matiasek K, Greene CE, Hartmann K, Fischer A.

J Am Vet Med Assoc. 2007 Jan 15;230(2):199-205.

PMID:
17223751
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk